Use of targeted therapy in patients with metastatic renal cell carcinoma: clinical and economic impact in a Canadian real-life setting

INTRODUCTION: Outside of randomized controlled clinical trials, the understanding of the effectiveness and costs associated with targeted therapies for metastatic renal cell carcinoma (mrcc) is limited in Canada. The purpose of the present study was to use real-world prospective data to assess the e...

詳細記述

保存先:
書誌詳細
出版年:Curr Oncol
主要な著者: Nazha, S., Tanguay, S., Kapoor, A., Jewett, M., Kollmannsberger, C., Wood, L., Bjarnason, G., Heng, D., Soulières, D., Reaume, N., Basappa, N., Lévesque, E., Dragomir, A.
フォーマット: Artigo
言語:Inglês
出版事項: Multimed Inc. 2018
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6291289/
https://ncbi.nlm.nih.gov/pubmed/30607126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.25.4103
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料